Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS). World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes (Q73200635)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 1999

Language	Label	Description	Also known as
English	Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS). World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes	scientific article published on 01 November 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS). World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

World Health Organization

1 reference

based on heuristic

inferred from title

author name string

G Steiner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Stewart

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J D Hosking

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

84

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1004-1010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Comparison of European and USA guidelines for prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

The dyslipoproteinemias of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900488-9

7 January 2021

Identifiers

10.1016/S0002-9149(99)00488-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569654%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73200635&oldid=1766457941"